Streetbeat News

Products Services

GSK

GSK presented late-breaking data at the ERS showing that their drug Depemokimab significantly reduces severe asthma exacerbations by 54% in Phase III trials. The SWIFT-1 and SWIFT-2 studies demonstrated meaningful reductions over 52 weeks compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:38 pm

HALB

Halberd Corp. has issued a letter to shareholders discussing the evolving PTSD market and their innovative solutions, including the WatchDawg and LDX medication combination. The company highlights advancements in PTSD treatment, government support, and the integration of mental health services. They emphasize their wearable technology for real-time health monitoring and the potential for franchising their WatchDawg business model. Halberd is pursuing FDA Fast Track designation for their LDX solution and exploring Breakthrough Therapy designation.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:33 pm

GNPX

Genprex, Inc. announced that its collaborators will present preclinical data on Reqorsa Gene Therapy at the 2024 EORTC-NCI-AACR Symposium. The data focuses on treating Ras inhibitor resistant lung cancer, mesothelioma, and glioblastoma.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:33 pm

NXT

Nextracker (NASDAQ:NXT) has launched NX Foundation Solutions, including the NX Anchor system, to enhance solar project development across various soil types. This follows Nextracker's recent acquisitions of Ojjo and Solar Pile International's foundations business.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:30 pm

GFS

GlobalFoundries (NASDAQ:GFS) partners with Silicon Catalyst to support semiconductor startups by providing access to its platforms, aiding in the development of IoT, automotive, and AI applications.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:29 pm

TERN

Terns Pharmaceuticals announced positive Phase 1 trial results for its oral GLP-1 drug, TERN-601, showing significant weight loss in participants. The drug was well tolerated and demonstrated promising potential for treating obesity. TERN stock rose 14.6% in premarket trading.

Portfolio Pulse from Vandana Singh

September 09, 2024 | 1:24 pm

MULN

Mullen's subsidiary, Bollinger Motors, has received certification from the California Air Resources Board, enabling its customers to qualify for additional state incentives.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:16 pm

IMVT

TERN

Terns Pharmaceuticals and Immunovant are two health care stocks that may face short-term declines due to being overbought, as indicated by their high RSI values. Both companies have recently reported positive trial results, leading to significant stock gains.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 1:12 pm

TSLA

Tesla shares are rising as Panasonic, a key supplier, has completed preparations for mass production of high-capacity EV batteries, specifically the 4680 cells, at its Wakayama plant.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:12 pm

ELF

MTCH

e.l.f. Cosmetics has partnered with Tinder to launch a limited-edition 'Put Your e.l.f. Out There' Vault Collection. This collaboration aims to combine beauty innovations with exclusive products to boost confidence and ease first-date jitters.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:10 pm